Men’s Health
-
NHS to trial new prostate screening techniques
The NHS is to launch a major prostate cancer screening trial, it has been announced. Read more
-
Advanced prostate cancer drug resistance ‘reversed’
Drug resistance in prostate cancer could be reversed by blocking the messages that target white blood cells, according to new research involving British scientists. Read more
-
Call for global action to address declining male fertility
Urgent, global action is needed to address male infertility, according to a new report from an international consortium. Read more
-
Genomics uncovers syphilis transmission networks
Genomics has helped to reveal distinct sexual networks for syphilis transmission – showing how drug resistance develops, according to a major UK study. Read more
-
Drop in mpox cases examined
Changes in behaviour were probably the key reason for the stemming of the mpox outbreak in England last year, according to a new analysis. Read more
-
Rising ADHD prescription rates revealed
Prescriptions for attention deficit hyperactivity disorder have increased “significantly” in the UK this century, according to an analysis published today. Read more
-
Warning over seasonal Mpox threat
Mpox remains a threat to Europe, the World Health Organization has warned. Read more
-
Weight gain linked to riskier prostate cancer
Weight gain in the late teens and 20s may increase the risk of prostate cancer mortality later in life, a European conference has heard. Read more
-
NHS backs olaparib for breast and prostate cancer
A decision today to allow olaparib for NHS patients with both early-stage breast cancer and prostate cancer has been hailed a “life-changing” decision by leading specialists. Read more
-
Pandemic safe sexual activity had lasting impact
The reduction in “risky” sexual activity during the early stages of the COVID-19 pandemic continued for a year after Britain’s first lockdown, according to a major new study published today. Read more